• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性腹膜透析患者血清氧化三甲胺与动脉僵硬度的关系:一项横断面研究

The Association Between Serum Trimethylamine -Oxide and Arterial Stiffness in Chronic Peritoneal Dialysis Patients: A Cross-Sectional Study.

作者信息

Huang Po-Yu, Lin Yu-Li, Chen Yi-Hsin, Hung Szu-Chun, Liou Hung-Hsiang, Tsai Jen-Pi, Hsu Bang-Gee

机构信息

Institute of Medical Sciences, Tzu Chi University, Hualien 97004, Taiwan.

Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan.

出版信息

Toxins (Basel). 2024 Dec 3;16(12):523. doi: 10.3390/toxins16120523.

DOI:10.3390/toxins16120523
PMID:39728781
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11728722/
Abstract

Trimethylamine -oxide (TMAO), a gut microbiome-derived metabolite, participates in the atherogenesis and vascular stiffening that is closely linked with cardiovascular (CV) complications and related deaths in individuals with kidney failure undergoing peritoneal dialysis (PD) therapy. In these patients, arterial stiffness (AS) is also an indicator of adverse CV outcomes. This study assessed the correlation between serum TMAO concentration quantified with high-performance liquid chromatography and mass spectrometry and central AS measured by carotid-femoral pulse wave velocity (cfPWV) in patients with chronic PD. Of the 160 participants included, 23.8% had a cfPWV of ≥10 m/s, which fulfilled the AS criteria. Multivariable logistic regression analysis revealed that TMAO, age, and waist circumference were positively associated with AS. Multivariable stepwise linear regression showed that underlying diabetes, advanced age, waist circumference, systolic blood pressure, and logarithmic-transformed TMAO were independently correlated with cfPWV. The area under the receiver operating characteristic curve for TMAO in differentiating AS from non-AS was 0.737. In conclusion, serum TMAO level was significantly independently correlated with central AS among participants undergoing PD for end-stage kidney failure.

摘要

氧化三甲胺(TMAO)是一种源自肠道微生物群的代谢产物,参与动脉粥样硬化的形成和血管硬化过程,而这与接受腹膜透析(PD)治疗的肾衰竭患者的心血管(CV)并发症及相关死亡密切相关。在这些患者中,动脉僵硬度(AS)也是不良心血管结局的一个指标。本研究评估了采用高效液相色谱和质谱法定量的血清TMAO浓度与通过颈股脉搏波速度(cfPWV)测量的中心动脉僵硬度之间的相关性,研究对象为慢性腹膜透析患者。在纳入的160名参与者中,23.8%的人cfPWV≥10 m/s,符合动脉僵硬度标准。多变量逻辑回归分析显示,TMAO、年龄和腰围与动脉僵硬度呈正相关。多变量逐步线性回归表明,潜在糖尿病、高龄、腰围、收缩压以及对数转换后的TMAO与cfPWV独立相关。TMAO区分动脉僵硬度与非动脉僵硬度的受试者工作特征曲线下面积为0.737。总之,在接受终末期肾衰竭腹膜透析的参与者中,血清TMAO水平与中心动脉僵硬度显著独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0cc/11728722/0e9749f2b42a/toxins-16-00523-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0cc/11728722/0e9749f2b42a/toxins-16-00523-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0cc/11728722/0e9749f2b42a/toxins-16-00523-g001.jpg

相似文献

1
The Association Between Serum Trimethylamine -Oxide and Arterial Stiffness in Chronic Peritoneal Dialysis Patients: A Cross-Sectional Study.慢性腹膜透析患者血清氧化三甲胺与动脉僵硬度的关系:一项横断面研究
Toxins (Basel). 2024 Dec 3;16(12):523. doi: 10.3390/toxins16120523.
2
Serum Trimethylamine -Oxide Level Is Positively Associated with Aortic Stiffness Measured by Carotid-Femoral Pulse Wave Velocity in Patients Undergoing Maintenance Hemodialysis.血清三甲胺氧化物水平与维持性血液透析患者颈动脉-股动脉脉搏波速度测量的动脉僵硬度呈正相关。
Toxins (Basel). 2023 Sep 17;15(9):572. doi: 10.3390/toxins15090572.
3
Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.在血液透析患者中,血清骨保护素是使用颈股脉搏波速度评估的中心动脉僵硬度的独立标志物:一项横断面研究。
BMC Nephrol. 2019 May 23;20(1):184. doi: 10.1186/s12882-019-1374-2.
4
Serum Lipoprotein(a) Levels as a Predictor of Aortic Stiffness in Patients on Long-Term Peritoneal Dialysis.血清脂蛋白(a)水平可预测长期腹膜透析患者的主动脉僵硬度。
Med Sci Monit. 2024 Jun 5;30:e944348. doi: 10.12659/MSM.944348.
5
Connections between serum Trimethylamine N-Oxide (TMAO), a gut-derived metabolite, and vascular biomarkers evaluating arterial stiffness and subclinical atherosclerosis in children with obesity.血清三甲胺 N-氧化物(TMAO)与血管生物标志物之间的关系,TMAO 是一种肠道衍生代谢物,可评估肥胖儿童的动脉僵硬度和亚临床动脉粥样硬化。
Front Endocrinol (Lausanne). 2023 Oct 2;14:1253584. doi: 10.3389/fendo.2023.1253584. eCollection 2023.
6
Serum Trimethylamine N-Oxide Level Is Associated with Peripheral Arterial Stiffness in Advanced Non-Dialysis Chronic Kidney Disease Patients.血清三甲胺 N-氧化物水平与晚期非透析慢性肾脏病患者的外周动脉僵硬度相关。
Toxins (Basel). 2022 Jul 31;14(8):526. doi: 10.3390/toxins14080526.
7
Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.透析初治患者中氧化三甲胺与营养和炎症生物标志物及心血管结局的关联
J Ren Nutr. 2015 Jul;25(4):351-6. doi: 10.1053/j.jrn.2015.02.006. Epub 2015 Mar 19.
8
Elevated Serum Trimethylamine N-Oxide Levels Are Associated with Mortality in Male Patients on Peritoneal Dialysis.血清三甲胺 N-氧化物水平升高与腹膜透析男性患者的死亡率相关。
Blood Purif. 2021;50(6):837-847. doi: 10.1159/000512962. Epub 2021 Feb 17.
9
Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases.载脂蛋白 A1 与心血管疾病风险因素的中年患者的心血管风险和血管改变的关联。
Biosci Rep. 2024 Apr 29;44(5). doi: 10.1042/BSR20232090.
10
Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients.血清硬骨素而不是 DKK-1 与终末期肾病患者的中心动脉僵硬相关。
Int J Environ Res Public Health. 2020 Feb 14;17(4):1230. doi: 10.3390/ijerph17041230.

引用本文的文献

1
Gut-derived uremic toxins and cardiovascular health in chronic kidney disease.慢性肾脏病中肠道源性尿毒症毒素与心血管健康
Tzu Chi Med J. 2025 Apr 11;37(3):264-274. doi: 10.4103/tcmj.tcmj_293_24. eCollection 2025 Jul-Sep.

本文引用的文献

1
Association of the trimethylamine N-oxide with cardiovascular risk and vascular alterations in middle-aged patients with risk factors for cardiovascular diseases.载脂蛋白 A1 与心血管疾病风险因素的中年患者的心血管风险和血管改变的关联。
Biosci Rep. 2024 Apr 29;44(5). doi: 10.1042/BSR20232090.
2
Time-dependent specific molecular signatures of inflammation and remodelling are associated with trimethylamine-N-oxide (TMAO)-induced endothelial cell dysfunction.炎症和重构的时变特异性分子特征与三甲胺 N-氧化物(TMAO)诱导的内皮细胞功能障碍有关。
Sci Rep. 2023 Nov 20;13(1):20303. doi: 10.1038/s41598-023-46820-7.
3
Can we reverse arterial stiffness by intervening on CKD-MBD biomarkers?
我们能否通过干预慢性肾脏病-矿物质和骨异常生物标志物来逆转动脉僵硬度?
Clin Kidney J. 2023 May 15;16(11):1766-1775. doi: 10.1093/ckj/sfad112. eCollection 2023 Nov.
4
Pathophysiological concepts and screening of cardiovascular disease in dialysis patients.透析患者心血管疾病的病理生理概念与筛查
Front Nephrol. 2023 Sep 29;3:1198560. doi: 10.3389/fneph.2023.1198560. eCollection 2023.
5
Serum Trimethylamine -Oxide Level Is Positively Associated with Aortic Stiffness Measured by Carotid-Femoral Pulse Wave Velocity in Patients Undergoing Maintenance Hemodialysis.血清三甲胺氧化物水平与维持性血液透析患者颈动脉-股动脉脉搏波速度测量的动脉僵硬度呈正相关。
Toxins (Basel). 2023 Sep 17;15(9):572. doi: 10.3390/toxins15090572.
6
Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide.肾功能与循环三甲基胺 N-氧化物之间存在因果关系和可调节关系的证据。
Nat Commun. 2023 Sep 20;14(1):5843. doi: 10.1038/s41467-023-39824-4.
7
The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review.三甲基胺 N-氧化物在动脉粥样硬化中的作用及其潜在的治疗方面:文献综述。
Biomol Biomed. 2023 Nov 3;23(6):936-948. doi: 10.17305/bb.2023.8893.
8
Determinants of arterial stiffness in patients with type 2 diabetes mellitus: a cross sectional analysis.2 型糖尿病患者动脉僵硬度的决定因素:一项横断面分析。
Sci Rep. 2023 Jun 2;13(1):8944. doi: 10.1038/s41598-023-35589-4.
9
Gut microbiota-derived trimethylamine N-oxide is associated with the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease: a systematic review and dose-response meta-analysis.肠道微生物衍生的三甲胺 N-氧化物与慢性肾脏病患者全因和心血管死亡率的风险相关:系统评价和剂量反应荟萃分析。
Ann Med. 2023 Dec;55(1):2215542. doi: 10.1080/07853890.2023.2215542.
10
Role of the Gut Microbiome in the Development of Atherosclerotic Cardiovascular Disease.肠道微生物群在动脉粥样硬化性心血管疾病发展中的作用。
Int J Mol Sci. 2023 Mar 12;24(6):5420. doi: 10.3390/ijms24065420.